Skip to content

Filling critical evidence generation gaps with global oncology real-world data

Published

August 2024

By

Blythe Adamson, PhD, MPH

There is increasing demand for local data as regulatory and HTA bodies have stated a clear preference in RWE guidances. Watch Flatiron’s Blythe Adamson MD, Head of Outcomes Research & Evidence Generation, share more about how we’re filling the gap with RWD from the US, UK, Germany, and Japan.

 
Filling critical evidence generation gaps with global oncology real-world data

Share